Modeling hereditary cardiac disease with patient-specific-induced pluripotent stem cells: opportunities and concerns

J Cardiovasc Pharmacol. 2012 Oct;60(4):406-7. doi: 10.1097/FJC.0b013e31825f3f0f.
No abstract available

MeSH terms

  • Animals
  • Cell Differentiation
  • Disease Models, Animal
  • Drug Design
  • Heart Diseases / genetics
  • Heart Diseases / physiopathology*
  • Humans
  • Induced Pluripotent Stem Cells / metabolism*
  • Models, Biological*
  • Species Specificity